For the past several years, success has grown more elusive for American biotech firms, grappling with a confluence of shifting…
Read More
Boehringer Ingelheim eyes MASH as the next front for survodutide, a GLP-1/glucagon receptor dual agonist
For decades, fatty liver disease, and its more severe inflammatory progression known as metabolic dysfunction-associated steatohepatitis (MASH), remained largely overlooked…
Read MoreAmerican Diabetes Association Conference Sees Landmark GLP-1 Trial Results Amidst Unprecedented Controversy Over Researcher Removal
The annual national conference of the American Diabetes Association (ADA) this week served as a pivotal platform for unveiling cutting-edge…
Read More
Novo Nordisk hands a Parkinson’s cell therapy to Cellular Intelligence, a startup trying to design cell behavior
Cellular Intelligence, a rapidly emerging biotech startup formerly known as Somite AI, has secured global rights to a clinical-stage Parkinson’s…
Read More
FDA Commissioner Marty Makary Resigns Amidst Mounting Pressure and Regulatory Turmoil
Marty Makary resigned on Tuesday as commissioner of the Food and Drug Administration, a departure precipitated by intense administrative pressure…
Read More
J&J Poster Puts Spravato Remission Data at Center of Treatment-Resistant Depression Growth Push
More than six decades after Calvin Stevens first synthesized ketamine at Parke-Davis in a quest for a safer anesthetic, the…
Read More
CNPV: A gamechanger for the pharma industry or simply more chaos?
The pharmaceutical industry finds itself at a pivotal juncture with the advent of the U.S. Food and Drug Administration’s (FDA)…
Read More
FUJIFILM Biotechnologies COO Maja Herold Pedersen on AI, autonomy and the path from quality to operations
FUJIFILM Biotechnologies, a prominent contract development and manufacturing organization (CDMO), is currently experiencing an unprecedented period of expansion, marked by…
Read More
Canada approves generic semaglutide from Dr. Reddy’s, a G7 first enabled by Novo Nordisk’s lapsed CAD$250 patent
In a landmark decision poised to reshape access to one of the world’s most in-demand medications, Health Canada has granted…
Read More
Top pharma companies set sustainability goals, but emissions are still increasing
The global healthcare industry, a cornerstone of human well-being and longevity, is simultaneously a significant contributor to the planet’s environmental…
Read More
